NAS:HRTS

Tema GLP-1 Obesity & Cardiometabolic ETF

$ 28.5 0.135 ( +0.48%) 03:54 PM EST
PE Ratio:
34.11
PB Ratio:
5.03
Volume:
5.72K
Dividend Yield %:
0.5
Last Holding update 2025-04-22 43 Stocks (11 new)
Value $66.00 Mil Turnover 34 %
Top Holdings: LLY(10.79%) UNH(5.28%) OCSE:NOVO B(4.37%) LSE:AZN(4.08%) BBIO(4.00%)
Portfolio Report
Registrant: Tema GLP-1, Obesity & Cardiometabolic ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Tema GLP-1 Obesity & Cardiometabolic ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Tema GLP-1 Obesity & Cardiometabolic ETF Key Statistics

Name Value
Day's Open ($) 27.9927
Day's Range ($) 27.92 - 28.53
Day's Volume 5,717
52-Week Range ($) 25.32 - 36.03
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility 18.38
14-Day RSI 50.88
14-Day ATR ($) 0.63917
20-Day SMA ($) 27.87425

Fundamental Data

Name Value
Market Cap (Mil $) 55.222
Shares Outstanding (Mil) 1.94
PE Ratio 34.11
PE Ratio (10y Range) -
PE Ratio (10y Median) -
PB Ratio 5.03
PB Ratio (10y Range) -
PB Ratio (10y Median) -

Dividend Data

Name Value
Dividends per Share (TTM) ($) -
Dividend Yield % 0.5
Dividend Yield % (10y Range) -
Dividend Yield % (10y Median) -
Next Dividend Payment Date
Dividend Frequency -

HRTS Tema GLP-1 Obesity & Cardiometabolic ETF Fundamental Charts

Historical TTM Price-to-Earnings for HRTS Tema GLP-1 Obesity & Cardiometabolic ETF

Historical TTM Price-to-Earnings without NRI for HRTS Tema GLP-1 Obesity & Cardiometabolic ETF

Historical Price-to-Book Ratio for HRTS Tema GLP-1 Obesity & Cardiometabolic ETF

Historical Dividend Yields for HRTS Tema GLP-1 Obesity & Cardiometabolic ETF

Tema GLP-1 Obesity & Cardiometabolic ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with NAS:HRTS

No Available Data

NAS:HRTS is held by these investors

No Available Data
Tema GLP-1, Obesity & Cardiome... Top Holdings of 2025-02-28 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
LLY 		Eli Lilly and Co
7,731
7,117.4
+12.14%
10.790
+1.17%
0.000
+12.82%
+14.78%
794,307.3
Drug Manufacturers
UNH 		UnitedHealth Group Inc
7,327
3,480.0
New Holding
5.280
+5.28%
0.000
-21.05%
-16.89%
381,056.1
Healthcare Plans
OCSE:NOVO B 		Novo Nordisk AS
32,160
2,883.0
+15.31%
4.370
+0.58%
0.000
-34.09%
-34.28%
1,791,157.8
Drug Manufacturers
LSE:AZN 		AstraZeneca PLC
17,852
2,687.5
-13.27%
4.080
-0.46%
0.000
-4.11%
+1.22%
161,218.8
Drug Manufacturers
BBIO 		BridgeBio Pharma Inc
75,661
2,640.6
-34.79%
4.000
-1.36%
0.040
-3.42%
+32.31%
6,904.8
Biotechnology
ABT 		Abbott Laboratories
18,295
2,524.9
New Holding
3.830
+3.83%
0.000
+3.53%
+15.04%
223,467.6
Medical Devices & Instruments
RHHBY 		Roche Holding AG
58,928
2,459.7
New Holding
3.730
+3.73%
0.000
+7.32%
+17.07%
251,474.1
Drug Manufacturers
VRTX 		Vertex Pharmaceuticals Inc
4,996
2,397.0
-46.58%
3.640
-2.54%
0.000
+12.33%
+22.63%
126,956.8
Biotechnology
TSE:4519 		Chugai Pharmaceutical Co Ltd
45,231
2,249.6
-30.12%
3.410
-1.07%
0.000
+27.23%
+18.22%
13,615,080.5
Drug Manufacturers
MRK 		Merck & Co Inc
24,196
2,232.1
New Holding
3.390
+3.39%
0.000
-12.66%
-16.11%
208,206.5
Drug Manufacturers

Tema GLP-1, Obesity & Cardiometabolic ETF's Historical Top Holdings Breakdowns

Tema GLP-1, Obesity & Cardiometabolic ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
UNH 		UnitedHealth Group Inc2025-02-28New Buy
+5.28%
●
461.52 ($524.54) 610.79
$418.64
-20.19%
New holding
7,327
7,327
ABT 		Abbott Laboratories2025-02-28New Buy
+3.83%
●
111.1 ($121.37) 138.01
$128.85
6.16%
New holding
18,295
18,295
RHHBY 		Roche Holding AG2025-02-28New Buy
+3.73%
●
34.24 ($37.69) 42.04
$39.52
4.86%
New holding
58,928
58,928
MRK 		Merck & Co Inc2025-02-28New Buy
+3.39%
●
83.01 ($96.19) 103.79
$82.74
-13.98%
New holding
24,196
24,196
ALNY 		Alnylam Pharmaceuticals Inc2025-02-28Reduce
-3.38%
●
233.15 ($253.79) 279.19
$251.56
-0.88%
Reduce -69.45%
4,703
-10,692
TMO 		Thermo Fisher Scientific Inc2025-02-28New Buy
+3.11%
●
516.18 ($544.74) 606.74
$424.24
-22.12%
New holding
3,875
3,875
GILD 		Gilead Sciences Inc2025-02-28New Buy
+2.78%
●
89.14 ($96.3) 114.31
$103.17
7.13%
New holding
16,010
16,010
ABBV 		AbbVie Inc2025-02-28New Buy
+2.56%
●
169.2 ($182.55) 209.03
$186.06
1.92%
New holding
8,082
8,082
VRTX 		Vertex Pharmaceuticals Inc2025-02-28Reduce
-2.54%
●
396.64 ($446.07) 488.44
$493.84
10.71%
Reduce -46.58%
4,996
-4,356
ASND 		Ascendis Pharma AS2025-02-28Reduce
-2.38%
●
119.49 ($135.44) 156.58
$164.15
21.20%
Reduce -68.7%
6,396
-14,038

Tema GLP-1, Obesity & Cardiometabolic ETF Total Holding History ($B)

To

Tema GLP-1, Obesity & Cardiometabolic ETF's Asset Allocation

To

Tema GLP-1, Obesity & Cardiometabolic ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Tema GLP-1, Obesity & Cardiometabolic ETF's Hypothetical Growth since 2025-02-28

Tema GLP-1, Obesity & Cardiometabolic ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Tema GLP-1, Obesity & Cardiometabolic ETF's Holdings Heat Map

Size field:

Tema GLP-1, Obesity & Cardiometabolic ETF's Holdings Bubble Chart

Tema GLP-1, Obesity & Cardiometabolic ETF News

  • 1

Discussions on Tema GLP-1 Obesity & Cardiometabolic ETF

User's Avatar
How would you rate this stock? HRTS
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.